Oklahoma City, OK – In a significant leap forward for cancer research, scientists at the University of...
Sagoh
A pioneering investigational therapy, MGC030, developed by US-based biopharmaceutical company MacroGenics, has reached a significant milestone with...
Introduction: A Legacy Built on Compassion For many, Pride is defined by the vibrant spectacles of parades...
The intersection of artificial intelligence and pharmaceutical research has long been promised as a transformative frontier, a...
For decades, breast cancer has been framed almost exclusively as a women’s health crisis. Pink ribbons, feminine-centric...
Written by Douglas Feil, NBCF Chief Program Officer Disclaimer: The information provided in this article is for...
For decades, the standard of care for aggressive breast cancer followed a "more is better" philosophy. In...
The American Association of Pharmaceutical Scientists (AAPS) has announced the appointment of Dr. Patrick J. Sinko, Ph.D.,...
The relationship between the United States and the World Health Organization (WHO), once a bedrock of international...
An In-depth Examination of Emerging Research and Patient Considerations By Douglas Feil, NBCF Chief Program Officer In...
